Evidence map›Paper›PMID 20532128›Full record

ReviewDeutsches Arzteblatt international2010

The surgical treatment of hepatic metastases in colorectal carcinoma.

Ulf Peter Neumann, Daniel Seehofer, Peter Neuhaus

Open access · greenAbstract readReview
In one paragraph

Review in Deutsches Arzteblatt international, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 52 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Two-Stage Hepatectomy and ALPPS for Advanced Bilateral Liver Metastases: a Tailored Approach Balancing Risk and Outcome.Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract · 2019
    Article
  9. Article
  10. Article
  11. Article
  12. The Influence of Liver Resection on Intrahepatic Tumor Growth.Journal of visualized experiments : JoVE · 2016
    Article
  13. [Preoperative imaging/operation planning for liver surgery].Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen · 2015
    Review
  14. Article
  15. Review
  16. [Morbidity, mortality and analysis of prognostic factors for colorectal cancer].Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen · 2015
    Article
  17. The evolution of cancer surgery and future perspectives.Nature reviews. Clinical oncology · 2015
    Review
  18. Review
  19. Article
  20. Surgical intervention for pulmonary metastases.Deutsches Arzteblatt international · 2012
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Ulf Peter NeumannKlinik für Allgemein-, Viszeral- und Transplantationschirurgie, Charité-Universitätsmedizin Berlin, Campus Virchow-Klinikum, Berlin, Germany. chirurgie@ukaachen.de
Daniel Seehofer
Peter Neuhaus
Charité - Universitätsmedizin Berlin · DEUniversitätsklinikum Aachen · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundColorectal carcinoma with hepatic metastases was long considered an incurable disease. Recent advances in surgical treatment have substantially improved the affected patients' prognosis. At first, surgery was only performed in patients whose hepatic tumor burden was small (<4 nodes, <5 cm). Currently, however, the main issue is the feasibility of curative resection of all metastases.

methodThe PubMed literature database was selectively searched for articles with the keywords "colorectal liver metastases," "chemotherapy," and "surgery." Particular attention was devoted to studies of large groups of patients, randomized trials, the German guidelines, and an analysis of the authors' own patient population.

resultsOnly 10% to 20% of all patients are candidates for surgical therapy (hepatic resection), as the rest are disqualified either by extensive liver involvement or by extrahepatic neoplasia. A further 10% of patients have hepatic metastases that are primarily considered inoperable, yet later become amenable to surgery after interdisciplinary treatment involving preoperative chemotherapy, portal-vein embolization, two-stage hepatectomy, and/or locally ablative procedures. Chemotherapy is probably beneficial after hepatic resection, although the benefit has not yet been definitively demonstrated by clinical trials. Therefore, chemotherapy should only be given perioperatively in selected cases, when recommended by an interdisciplinary treatment team.

conclusionA multimodal approach to the treatment of hepatic metastases of colorectal carcinoma has led to an increase in the number of resections and to an improved long-term survival rate (currently more than 40% at 5 years).

Indexed as

Antineoplastic AgentsChemotherapy, AdjuvantColorectal NeoplasmsCombined Modality TherapyDisease-Free SurvivalEmbolization, TherapeuticHepatectomyHumansLiver NeoplasmsNeoadjuvant TherapyPatient Care TeamPortal VeinPrognosisTumor BurdenAntineoplastic Agents

Identifiers

PMID20532128
PMCPMC2881614
OpenAlexW2162432744

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.